FT.com / Health - Drug companies pool placebo information
A dozen large pharmaceutical companies will today unveil a groundbreaking project to share information on patients enrolled in their clinical trials for Alzheimer's disease, in an effort to accelerate the development of new treatments.
While keeping to themselves the more commercially sensitive information on patients' reactions to their competing experimental drugs, companies will share data on those in the placebo arm - receiving a simple sugar pill against which to compare the effect of their medicines.
No comments:
Post a Comment